drugset / Trial / NCT00038220
Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if a novel 4-drug anti-HIV combination can suppress the growth of HIV in patients infected with the virus.
Timeline
- Start
- 2000-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | — | — |
| Subject | Lamivudine | Other / unclassified | — | — |
| Subject | Lopinavir/ritonavir | Unknown | — | — |
| Subject | Tenofovir disoproxil fumarate | Small molecule | — | — |